Key result
Ablation of NPY-expressing neurons in the stellate ganglia significantly reduced maximal heart rate responses during high-frequency sympathetic stimulation compared to controls.
Why the study?
It was unknown whether cardiac-innervating stellate ganglionic neurons exhibit diversity and distinction from neurons innervating other tissues.
p-value: p=0.0009
Cardiac sympathetic regulation involves a two-tiered system where high-level sympathoexcitation requires recruitment of NPY-expressing neurons, offering potential novel targets for sympathetic blockade in cardiac disease.
Highlights NPY neurons for high-level sympathetic HR control in animals; leaves open targeted blockade as therapy in human cardiac disease.
The cell bodies of postganglionic sympathetic neurons innervating the heart primarily reside in the stellate ganglion (SG), alongside neurons innervating other organs and tissues. Whether cardiac-innervating stellate ganglionic neurons (SGNs) exhibit diversity and distinction from those innervating other tissues is not known. To identify and resolve the transcriptomic profiles of SGNs innervating the heart we leveraged retrograde tracing techniques using adeno-associated virus (AAV) expressing fluorescent proteins (GFP or Td-tomato) with single cell RNA sequencing. We investigated electrophysiologic, morphologic, and physiologic roles for subsets of cardiac-specific neurons and found that three of five adrenergic SGN subtypes innervate the heart. These three subtypes stratify into two subpopulations; high (NA1a) and low (NA1b and NA1c) Npy-expressing cells, exhibit distinct morphological, neurochemical, and electrophysiologic characteristics. In physiologic studies in transgenic mouse models modulating NPY signaling, we identified differential control of cardiac responses by these two subpopulations to high and low stress states. These findings provide novel insights into the unique properties of neurons responsible for cardiac sympathetic regulation, with implications for novel strategies to target specific neuronal subtypes for sympathetic blockade in cardiac disease.
No takes yet. Share an insight, caveat, or question.
Sharma et al. (2023) studied Sympathetic control of cardiac function. Ablation of NPY-expressing neurons in stellate ganglia vs. Control mice (DIO-EGFP injected) was evaluated on Heart rate change in response to high-frequency (10 Hz) electrical stimulation of the right stellate ganglion (p=0.0009). Ablation of NPY-expressing neurons in the stellate ganglia significantly reduced maximal heart rate responses during high-frequency sympathetic stimulation compared to controls.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: